Categories
Daily Compliance News

Daily Compliance News: July 2, 2026, The Is Bribery Good Edition

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings you compliance-related stories to start your day. Sit back, enjoy a cup of morning coffee, and listen in to the Daily Compliance News. All, from the Compliance Podcast Network. Each day, we consider four stories from the business world, compliance, ethics, risk management, leadership, or general interest for the compliance professional.

Top stories include:

  • Judges urge prosecutors to drop corruption charges against Netanyahu. (TimesofIsrael)
  • Can bribery be a good thing? (ProMarket)
  • Google ordered to pay $2bn in Swedish antitrust case. (FT)
  • After the scandal, McKinsey shakes up the Board. (WSJ)

To learn about the intersection of Sherlock Holmes and the modern compliance professional, check out Tom’s latest book, The Game is Afoot-What Sherlock Holmes Teaches About Risk, Ethics and Investigations on Amazon.com.

Categories
GSK in China: 13 Years Later

GSK In China: 13 Years Later – Episode 9: Anti-Corruption Enforcement and the Compliance Imperative

Thirteen years after the GSK China scandal exploded onto the global stage, its lessons remain as urgent as ever for compliance professionals and business leaders. In this podcast series, we revisit the case not simply as corporate history, but as a living cautionary tale about culture, incentives, third parties, investigations, and governance. Each episode explores what went wrong, why it went wrong, and how those failures still echo in today’s compliance and ethics landscape. Join me as we unpack the scandal and draw practical lessons for building stronger, more resilient organizations. This episode examines the GSK corruption scandal in China as a watershed moment when long-ignored anti-bribery laws were suddenly enforced, exposing multinationals that had treated systemic kickbacks as a cost of doing business.

It argues China’s crackdown under Xi Jinping reflected both domestic political necessity, restoring legitimacy through mass discipline of officials, and an economic pivot away from discretionary “toll booth” bureaucratic approvals that enable rent-seeking. The 2014 trial testimony of former energy regulator Liu Tienan is highlighted for publicly endorsing more market-based, objective processes as an anti-corruption remedy, signaling state intent. Economists estimated a $70B budget boost and a 0.1–0.5% growth lift from reduced corruption. For compliance leaders, the key takeaway is that only rigorous, evidence-backed anti-corruption programs, third-party due diligence, forensic auditing, hotlines, and aligned incentives can help distinguish rogue conduct from corporate strategy as enforcement tightens globally.

Key highlights:

  • Selective Enforcement Trap
  • Why Xi Cracked Down
  • Purging Party Corruption
  • Liu Tienan Trial Signals
  • Corruption Costs Billions

Resources:

GSK in China: A Game Changer for Compliance on Amazon.com

GSK in China: Anti-Bribery Enforcement Goes Global on Amazon.com

Tom Fox

Instagram

Facebook

YouTube

Twitter

LinkedIn

Ed. Note: the voices of the hosts, Timothy and Fiona, were created by Notebook LM based upon text written by Tom Fox

Categories
GSK in China: 13 Years Later

GSK In China: 13 Years Later – Compliance Lessons Learned

Thirteen years after the GSK China scandal exploded onto the global stage, its lessons remain as urgent as ever for compliance professionals and business leaders. In this podcast series, we revisit the case not simply as corporate history, but as a living cautionary tale about culture, incentives, third parties, investigations, and governance. Each episode explores what went wrong, why it went wrong, and how those failures still echo in today’s compliance and ethics landscape. Join me as we unpack the scandal and draw practical lessons for building stronger, more resilient organizations. In this episode, we dissect corporate compliance lessons from GSK’s corruption scandal in China and consider GSK’s flawed response to anonymous whistleblower reports, the “Inspector Clouseau imitation,” and situate it against an earlier whistleblower case.

The discussion explains how bribery was operationalized through a targeted Botox marketing plan (“Vasili”) and the use of travel agencies as cash conduits via fake conferences and why frequent internal audits and PwC still missed it due to financial-audit “materiality” standards, which are set at zero under the FCPA. It outlines needed controls such as proper approval level, legitimate business purpose, enforcement, and preventive design; warns about siloed “functional trap” risk management; critiques “Olympian pronouncements” undermined by “tone in the middle” and unofficial messaging; and distinguishes auditing from real-time monitoring, including relationship-monitoring software that flags anomalous communication patterns, raising a final question about preventing corruption without creating a surveillance state.

Key highlights:

  • GSK China Scandal Setup
  • Why Investigations Fail
  • Travel Agencies as ATMs
  • Auditing Materiality Trap
  • Unofficial Messaging
  • Monitoring vs Auditing

Resources:

GSK in China: A Game Changer for Compliance on Amazon.com

GSK in China: Anti-Bribery Enforcement Goes Global on Amazon.com

Tom Fox

Instagram

Facebook

YouTube

Twitter

LinkedIn

Ed. Note: the voices of the hosts, Timothy and Fiona, were created by Notebook LM based upon text written by Tom Fox

Categories
GSK in China: 13 Years Later

GSK In China: 13 Years Later – From Compliance Crisis to Business Redesign: GSK’s Business Comeback

Thirteen years after the GSK China scandal exploded onto the global stage, its lessons remain as urgent as ever for compliance professionals and business leaders. In this podcast series, we revisit the case not simply as corporate history, but as a living cautionary tale about culture, incentives, third parties, investigations, and governance. Each episode explores what went wrong, why it went wrong, and how those failures still echo in today’s compliance and ethics landscape. Join me as we unpack the scandal and draw practical lessons for building stronger, more resilient organizations. In this episode, we consider the maxim that treating major compliance failures as purely legal problems is a business mistake, using GlaxoSmithKline’s bribery allegations in China as a case study.

Chinese police alleged GSK funneled money through travel agencies to bribe doctors and hospital officials, triggering parallel investigations and severe operational and financial impacts, including a profits warning, declines in Advair sales (12% after a prior 15% drop), and a 14% annual share price fall. CEO Sir Andrew Witty responded by emphasizing innovation, executing a $20bn asset swap to shift away from higher-risk oncology toward vaccines and consumer health, severing sales-target links to rep pay, ending payments to doctors to promote products (from 2016), leveraging transparency, and welcoming whistleblowers. The script also frames China’s strategy risk, contrasting joint-venture protection in autos with GSK’s vulnerability as an isolated foreign operator.

Key highlights:

  • Business Fallout and Numbers
  • Scarecrow Compliance Analogy
  • CEO Witty Plays Offense
  • The $20 Billion Asset Swap
  • Rewriting Sales Incentives

Resources:

GSK in China: A Game Changer for Compliance on Amazon.com

GSK in China: Anti-Bribery Enforcement Goes Global on Amazon.com

Tom Fox

Instagram

Facebook

YouTube

Twitter

LinkedIn

Ed. Note: the voices of the hosts, Timothy and Fiona, were created by Notebook LM based upon text written by Tom Fox

Categories
Daily Compliance News

Daily Compliance News: April 24, 2026, The New Calculus on Self-Disclosure Edition

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings you compliance-related stories to start your day. Sit back, enjoy a cup of morning coffee, and listen in to the Daily Compliance News. All, from the Compliance Podcast Network. Each day, we consider four stories from the business world, compliance, ethics, risk management, leadership, or general interest for the compliance professional.

Top stories include:

  • Ex-RBS banker sentenced for bribery. (FT)
  • Malaysian King to pick new ABC head. (SCMP)
  • What are the risks bubbling inside private credit? (WSJ)
  • Hui Chen says new calculus on self-disclosure. (Law360)

For more information on the use of AI in Compliance programs, my new book, Upping Your Game, is available. You can purchase a copy of the book on Amazon.com.

To learn about the intersection of Sherlock Holmes and the modern compliance professional, check out my latest book, The Game is Afoot-What Sherlock Holmes Teaches About Risk, Ethics and Investigations on Amazon.com.

Categories
Blog

Betting the Game: Gambling, Integrity and the New Risk in Sports – A New Podcast from CPN

The Compliance Podcast Network is proud to announce the launch of a new 10-part podcast series, Betting the Game: Gambling, Integrity and the New Risk in Sports, co-hosted by Tom Fox and Mike DeBernardis. This new series comes at a moment when sports gambling has moved from the margins of the sports world to the center of the modern sports business. What was once viewed as taboo is now embedded in broadcasts, sponsorships, fan engagement, media strategy, and even the daily vocabulary of sports culture.

That transformation has created a new generation of questions about governance, compliance, and integrity. For compliance professionals, sports business leaders, and anyone concerned with institutional trust, the issue is no longer whether gambling is part of the sports landscape. It clearly is. The real question is whether the institutions that welcomed gambling into the mainstream have built governance systems strong enough to protect athletes, safeguard competition, and preserve public confidence.

That is the animating idea behind Betting the Game. This is more than a podcast about sports wagering. It is a series about governance under pressure. It is about what happens when powerful new revenue streams collide with the most important asset any sports institution possesses: credibility.

Why This Series Matters

At the Compliance Podcast Network, we have long believed that compliance lessons do not live only in deferred prosecution agreements, enforcement actions, and boardrooms. They also live where culture, incentives, and institutional accountability come together in real time. Few places illustrate that collision more clearly today than sports gambling.

Over the past several years, legalized sports betting has transformed the economics of sports. Leagues have entered into sportsbook partnerships. Media companies have integrated odds and betting analysis into coverage. College athletics has been drawn into the orbit of wagering markets. Athletes, coaches, officials, and support staff now operate in an environment where betting is not merely present; it is pervasive. It is everywhere.

That raises classic compliance questions. How do institutions manage conflicts of interest? How do they protect against insider risk? How do they design systems that move from punishment after the fact to prevention before the line is crossed? How do they align commercial strategy with ethics and integrity? These are not only sports questions. They are governance questions. That is why this series belongs on the Compliance Podcast Network.

A New Podcast for a New Risk Environment

Betting the Game brings together the worlds of compliance, governance, and sports business to examine how gambling has reshaped the sports ecosystem. The series examines both professional and amateur sports and asks what happens when betting markets, athlete conduct, media incentives, and institutional oversight collide.

Each episode explores a different integrity pressure point. Some of the stories are obvious: athletes placing bets, prop betting, and suspicious wagering activity. Others are more structural: media normalization, inside information, third-party access, college athlete harassment, and the tension between monetizing gambling and policing its risks. Taken together, the 10 episodes form a wide-ranging examination of how sports gambling became a compliance issue hiding in plain sight.

The 10-Episode Lineup

Episode 1: From Taboo to Business Model: How Gambling Entered the Sports Mainstream

This opening episode traces the arc from stigma to sponsorship and explains how sports betting became embedded in modern sports’ business model. It sets the stage for the series by asking whether governance, oversight, and ethics kept pace with commercialization.

Episode 2: The Athlete as Bettor: When Players Cross the Line

This episode examines one of the clearest integrity flashpoints in sports: the player who becomes the bettor. It explores why leagues draw hard lines around athlete gambling and whether education and prevention have kept up with enforcement.

Episode 3: Inside Information: The New Edge in the Betting Economy

Information now moves markets in real time, and sports are no exception. This episode looks at injury reports, lineup disclosures, and the people closest to teams who may have access to valuable non-public information.

Episode 4: Entourages, Interpreters, and the People Around the Star

Not every gambling risk begins with the athlete himself. This episode explores how trusted insiders, aides, interpreters, friends, and members of an athlete’s inner circle can become points of access, vulnerability, and control failure.

Episode 5: Fixing the Margins: Match-Fixing, Spot-Fixing, and Vulnerable Competitions

This episode moves beyond the Hollywood image of a fixed game and into the modern world of spot-fixing and manipulated moments. It examines how lower-profile competitions and narrow in-game events can create outsized integrity risks.

Episode 6: Campus Under Pressure: Gambling and the New Risks in College Sports

College athletics has become one of the most exposed fronts in the sports gambling era. This episode looks at student-athlete betting, bettor harassment, and the governance challenge of protecting young athletes in a betting-saturated environment.

Episode 7: Judgment on the Field: Officials, Suspicion, and the Gambling Lens

Officials now work under a new type of scrutiny, where every call can trigger both outrage and financial consequences. This episode examines how gambling has changed perceptions of officiating, trust, and legitimacy.

Episode 8: Prop Bets and Micro-Bets: Small Moments, Big Integrity Risks

Modern betting markets increasingly focus on narrow, highly specific events that can be easier to influence than a final score. This episode explores whether some betting products are creating integrity risks that sports governance was never designed to manage.

Episode 9: Can Sports Police What They Profit From? Data, Deals, and Integrity Monitoring

As leagues and media companies benefit financially from gambling growth, the oversight challenge becomes more complicated. This episode asks whether sports can be both a commercial partner in betting and a credible guardian of integrity.

Episode 10: What Comes Next: Building a Better Integrity Framework for Sports Gambling

The final episode turns from diagnosis to solutions. It outlines what stronger governance could look like, from education and monitoring to product limits, athlete protections, and a more mature integrity framework.

Compliance Lessons in a Sports Context

For the compliance professional, the value of this series is straightforward. Sports may be the setting, but the underlying issues will feel very familiar. Culture matters. Incentives matter. Tone at the top matters. Training matters. Monitoring matters. And perhaps most importantly, prevention matters more than reaction.

In the corporate world, we know that a policy on paper is not enough. The same is true in sports. If gambling is promoted as a normal part of fan engagement while integrity rules for insiders are poorly communicated or weakly reinforced, that is not a player problem alone. That is a governance problem. Betting the Game is designed to unpack exactly those issues in a way that speaks to both compliance professionals and sports business leaders.

Join Us for the Launch

The launch of Betting the Game: Gambling, Integrity and the New Risk in Sports marks an exciting expansion of the Compliance Podcast Network into one of the most timely and consequential issues in modern sports and governance. Tom Fox and Mike DeBernardis will guide listeners through the legal, ethical, cultural, and business implications of sports gambling with the practical, analytical lens that Compliance Podcast Network listeners expect.

The series launches on Friday, April 24, and will post every other Friday throughout our season. It is available on the Compliance Podcast Network and wherever you listen to great podcasts.

Categories
GSK in China: 13 Years Later

GSK In China: 13 Years Later – After the Humphreys Verdict: Managing Third-Party Risk When You Can’t Verify

Thirteen years after the GSK China scandal exploded onto the global stage, its lessons remain as urgent as ever for compliance professionals and business leaders. In this podcast series, we revisit the case not simply as corporate history, but as a living cautionary tale about culture, incentives, third parties, investigations, and governance. Each episode explores what went wrong, why it went wrong, and how those failures still echo in today’s compliance and ethics landscape. Join me as we unpack the scandal and draw practical lessons for building stronger, more resilient organizations. In this episode, we take a deep dive into the 2013 GSK China bribery scandal and examine why it remains one of the most important case studies in corporate compliance, governance, and culture. Our hosts are Timothy and Fiona.

The episode examines how multinational companies should manage third-party relationships and compliance in opaque markets like China when traditional intelligence-gathering is curtailed by privacy laws, using the case of corporate investigators Peter Humphreys and his wife Ying Zeng, who were hired by GSK to investigate a sex-tape scandal but were convicted and imprisoned for purchasing Chinese citizens’ personal data. The discussion highlights how the verdict created operational uncertainty for due diligence, M&A, supplier vetting, and anti-bribery efforts, and notes Humphrey’s claim that GSK withheld the fact that it faced internal whistleblower allegations of corruption. Drawing on DOJ expectations and an SCCE framework, it argues for shifting from “vet and forget” to continuous third-party management across five steps, reinforcing business justification, questionnaires, contracts, and ongoing oversight with mitigations like capped commissions, detailed invoice review, early audits, and use of public records and in-person interviews.

Key highlights:

  • Why Verification Matters
  • Privacy Laws Change Everything
  • When Partners Refuse Disclosure
  • Build Your Own Intelligence
  • Contract Controls and Oversight

Resources:

GSK in China: A Game Changer for Compliance on Amazon.com

GSK in China: Anti-Bribery Enforcement Goes Global on Amazon.com

Tom Fox

Instagram

Facebook

YouTube

Twitter

LinkedIn

Ed. Note: the voices of the hosts, Timothy and Fiona, were created by Notebook LM based upon text written by Tom Fox

Categories
GSK in China: 13 Years Later

GSK In China: 13 Years Later – The Verdicts

Thirteen years after the GSK China scandal exploded onto the global stage, its lessons remain as urgent as ever for compliance professionals and business leaders. In this podcast series, we revisit the case not simply as corporate history, but as a living cautionary tale about culture, incentives, third parties, investigations, and governance. Each episode explores what went wrong, why it went wrong, and how those failures still echo in today’s compliance and ethics landscape. Join me as we unpack the scandal and draw practical lessons for building stronger, more resilient organizations.

This episode analyzes the GSK China scandal and its compliance implications, beginning with the 2014 Shanghai trial of private investigators Peter Humphrey and Yu Yingzeng, convicted under a vague 2009 privacy law for illegally purchasing sensitive personal data (IDs, travel, and phone records) using hidden cameras and data brokers, resulting in prison terms and fines. Their arrest overlapped with a GSK-commissioned probe into a sex tape involving China chief Mark Reilly, as China separately convicted GSK in a secret Hunan trial, imposing a record 3 billion RMB (~$491M) fine tied to bribes routed through travel agencies via inflated conference budgets and kickbacks to doctors. Executives gave televised confessions yet received suspended sentences, reflecting a strategy of corporate submission and public exposure over incarceration. The market reaction was muted, but GSK responded by ending payments to doctors and replacing volume-based sales commissions with qualitative metrics, creating a modern compliance blueprint while highlighting ongoing UK Bribery Act and FCPA exposure. Our hosts are Timothy and Fiona.

Key highlights:

  • Investigators on Trial
  • GSK Secret Verdict
  • Executives Sentenced
  • Judicial Strategy Explained
  • Global Compliance Blueprint

Resources:

GSK in China: A Game Changer for Compliance on Amazon.com

GSK in China: Anti-Bribery Enforcement Goes Global on Amazon.com

Tom Fox

Instagram

Facebook

YouTube

Twitter

LinkedIn

Ed. Note: the voices of the hosts, Timothy and Fiona, were created by Notebook LM based upon text written by Tom Fox

Categories
SBR - Authors' Podcast

SBR-Author’s Podcast: Bribery Beyond Borders: The Hidden History and Future of the FCPA with Severin Wirz

Welcome to the SBR-Author’s Podcast! In this podcast series, Host Tom Fox visits with authors in the compliance arena and beyond. In this episode, Tom Fox welcomes Severin Wirz, Senior Director for Ethics and Compliance at Applied Materials and author of “Bribery Beyond Borders: The Story of the Foreign Corrupt Practices Act.”

The book is about the origins, narrative approach, and future of FCPA enforcement. Severin explains he used storytelling to challenge conventional views that the FCPA was merely post-Watergate morality or the product of Stanley Sporkin alone, tracing a longer lineage of U.S. anti-corruption laws (Federal Corrupt Practices Act, Travel Act, Hobbs Act, RICO, Bank Secrecy Act) instead. He recounts the United Brands/Eli Black scandal, Wall Street Journal reporting that broke key bribery revelations, Stanley Sporkin’s role at the SEC, and the legislative influence of Frank Church and William Proxmire amid debates over disclosure, criminalization, and books-and-records provisions. Severin discusses shifting geopolitical drivers of enforcement and recommends related reading and contact options.

Key highlights:

  • Severin’s Compliance Journey
  • Writing FCPA as a Thriller
  • Eli Black Scandal Breaks
  • Sporkin and SEC Momentum
  • Journalists Connect the Dots
  • Frank Church and Cold War Stakes
  • Proxmire Gets It Passed
  • Three Visions of the FCPA
  • Future Enforcement and Geopolitics

Resources:

Severin Wirz on LinkedIn

Bribery Beyond Borders: The Story of the Foreign Corrupt Practices Act on CCI and Amazon.

Tom Fox

Instagram

Facebook

YouTube

Twitter

LinkedIn

Categories
From the Editor's Desk

From the Editor’s Desk: Aaron Nicodemus Reflections on March and April in Compliance Week

In this episode of From the Editor’s Desk, Tom Fox sits down with Aaron Nicodemus for a lively and insightful look back at the biggest compliance stories from March, while also previewing the trends, enforcement issues, and events set to shape April. They also begin the countdown to the 2026 Compliance Week National Conference in May.

Tom and Aaron break down the fast-moving, policy-driven shifts in U.S. sanctions on Venezuela, Iran, and Russia, and explore how companies are balancing business opportunities with escalating geopolitical and compliance risks amid a volatile oil market. They spotlight Compliance Week’s feature on illegal mining, unpacking its deep connections to financial crime, corruption, and supply chain exposure. The conversation also examines a notable March FCPA declination under the DOJ’s new Corporate Enforcement Policy, focusing on what it signals about voluntary self-disclosure, remediation, cooperation credit, and the Department’s continued emphasis on prosecuting individuals. Along the way, they consider possible aggravating factors, including payments tied to designated criminal or terrorist groups, and what these developments may mean for the future of cross-border enforcement cooperation.

Looking ahead, Tom and Aaron preview the 2026 Compliance Week National Conference, taking place May 6–8 in Washington, DC, including awards finalists, anticipated remarks from DOJ and SEC officials, and timely sessions on AI, whistleblowers, and emerging compliance challenges. They also highlight the conference’s expanded commitment to new voices and share an early look at the Third Party Risk Management & Supply Chain Summit, coming October 26–28 in Chicago.

 

 Resources:

Aaron Nicodemus on LinkedIn

Compliance Week